Financials

IDXG fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Interpace Biosciences, Inc.

Total assets of IDXG for Q1 25 is 14.49 M USD, 2.01% less than the previous Q4 24. And total liabilities decreased by 11.36% in Q1 25 to 15.08 M USD.

Q2 '17

Q3 '17

Q4 '17

Q1 '18

Q2 '18

Q3 '18

Q4 '18

Q1 '19

Q2 '19

Q3 '19

Q4 '19

Q1 '20

Q2 '20

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD